Silo Pharma shares are trading higher after the company entered into an agreement with WuXi AppTec for a preclinical small animal study of SPU-16.
Portfolio Pulse from Benzinga Newsdesk
Silo Pharma shares are trading higher after the company entered into an agreement with WuXi AppTec for a preclinical small animal study of SPU-16.
August 07, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Silo Pharma shares are trading higher following the announcement of a partnership with WuXi AppTec for a preclinical small animal study of SPU-16.
The partnership with WuXi AppTec for a preclinical study is a positive development for Silo Pharma, indicating progress in their research and development efforts. This news has led to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100